ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Expanded Liquid Chromatography-Mass Spectrometry Platform Provides All-in-One Toxicology Solution

Thermo Scientific Tox Explorer Collection solves complex analytical challenges and increases laboratory productivity

ASMS 2022 - Thermo Fisher Scientific Inc., the world leader in serving science, is providing forensic toxicologists, clinical research toxicologists, employee drug testing facilities, and wellness organizations with an all-in-one liquid chromatography-mass spectrometry (LC-MS) toxicology solution to keep pace with the ever-changing landscape of emerging and illicit drugs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220606005313/en/

Thermo Scientific Tox Explorer Collection (Photo: Business Wire)

Thermo Scientific Tox Explorer Collection (Photo: Business Wire)

The expansion of the Thermo Scientific Tox Explorer Collection onto the Thermo Scientific Orbitrap Exploris Mass Spectrometer platform provides access to ultra-high-resolution mass spectrometry specifically required to identify analytes in complex matrices, increasing laboratory productivity and improving the specificity and selectivity of toxicology analysis. This toxicology solution offers a standardized method with LC retention times that allows users to get up and running fast. It utilizes a comprehensive high-resolution accurate mass (HRAM) spectral library that has been expanded to over 1,700 compounds, enabling toxicology scientists to screen and quantify a wide and diverse range of compounds, with different hydrophobicities and polarities. The library also includes 212 fentanyl analogs, making it the largest fentanyl HRAM library to date. This solution comes complete with the software, service and support to sustain laboratory productivity.

Thermo Fisher Scientific is showcasing the Tox Explorer Collection during the 70th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, being held June 5-9, 2022 in Booth 400 at the Minneapolis Convention Center, Minneapolis, Minnesota and at the Hilton Minneapolis Grand Ballrooms E, F, G.

“The increase in illicit drug use and introduction of new synthetic drugs every year present challenges to the toxicology community in forensics, clinical research and sports anti-doping,” said Bradley Hart, senior director, analytical sciences and life science mass spectrometry, Thermo Fisher Scientific. “This expansion of the Tox Explorer Collection offers an all-in-one LC-MS solution to help our customers navigate these complexities with ease, solving complex analytical challenges with a comprehensive method from sample acquisition to reporting.”

Simon Hudson, technical director, LGC ASSURE, states, “We have developed an in-house broad coverage ‘open’ screen for NPS, drugs of abuse and medications based on Thermo Scientific Orbitrap Q Exactive mass spectrometers that has allowed us to successfully deliver forensic toxicology services for the past 10 years.

The use of the Tox Explorer Collection on the Exploris 120 mass spectrometer has significantly enhanced this screening service in several ways. Additional analytes in the database have provided enhanced coverage, helping in the identification of unique compounds in various coroner’s cases. Also, the greater scan speed of the Exploris MS allows complex acquisition workflows, including polarity switching and targeted data dependent MS2 (ddMS2) in a single analysis. Overall, the Tox Explorer Collection for Orbitrap Exploris 120 MS provides a powerful solution for forensic toxicology.”

Features of the Thermo Scientific Tox Explorer Collection include:

  • LC method with retention times on Vanquish Flex Binary UPLC system allows laboratories to get up and running quickly.
  • Accucore phenyl hexyl column enables high-resolution separation of a wide range of analytes without high backpressure.
  • Thermo Scientific Orbitrap Exploris 120 MS provides ultra-high-resolution MS, HRAM specificity and polarity switching for fast, accurate and reportable results.
  • Compound database and HRAM spectral library provides users with experimentally obtained high-resolution mass spectral information of over 1,700+ drugs of abuse, novel psychoactive substances (NPS), prescription drugs, etc. contained in the mzVault MS/MS library.
  • TraceFinder 5.1 software is a single software solution for data acquisition, processing and reporting that enables screening, quantitation and identification of compounds to be performed in one software package.
  • Customizability: The library can be easily added to or modified; subset libraries may be created with or without retention times for increased flexibility.
  • Sample preparation guidelines are provided for different matrices to clean up matrix interferences before injection into the LC-MS instrument.
  • Retrospective analysis provides the ability to reprocess data that was previously collected in a non-targeted manner.

For more information on the Thermo Fisher solutions exhibited at ASMS 2022, please visit www.thermofisher.com/ASMS.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.00
+2.08 (1.00%)
AAPL  264.18
-8.77 (-3.21%)
AMD  213.84
+0.00 (0.00%)
BAC  49.83
-2.47 (-4.72%)
GOOG  311.43
+4.28 (1.39%)
META  648.18
-8.83 (-1.34%)
MSFT  389.00
+0.00 (0.00%)
NVDA  177.19
-7.70 (-4.16%)
ORCL  145.40
-4.91 (-3.27%)
TSLA  402.51
-6.07 (-1.49%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.